Skip to main content
. 2024 Apr 24;13:e52090. doi: 10.2196/52090

Table 2.

Table of measuresa.

Survey measures Total number of items, n Screener, n Baseline, n Postrandomization, n Week 1 to week 6, n Week 28, n
Screener Survey 41 41 b
6-Item Cognitive Impairment Test (cognitive screener; eligibility) 7 7
Rapid Estimate of Adult Literacy in Medicine-Short Form [50] (eligibility) 9 9
Demographics or background information 19 19
MacArthur Scale of Subjective Social Status 2 2 2 2
Everyday Discrimination Scale 10 10
HIV adherence and treatment 17 17 17
Qualitative interview 24 (MASP+c); 20 (QGd) 24 (MASP+ week 6); 20 (QG)
ARTe adherence 6 6 6 (week 6) 6
AIDS Clinical Trials Group Adherence Questionnaire 24 24 19 (week 6) 19
Index of Engagement in HIV Care 10 10 10 (week 6) 10
WHOf Quality of Life-HIV 36 36 8 (week 6) 8
Carbon Monoxide Analysis (Phone Bedfont iCOg) 1 1 1 1
SSASIh (eligibility) 5 5 5 5 5
System Usability Scale 10 10 (week 6)

aVarious measures will be deployed during the eligibility screener, baseline and randomization surveys, weekly surveys, and daily EMAs. Daily EMAs will include items assessing sleep quality, HIV medication adherence, and discrimination, whereas random and event EMAs will include items assessing social interactions and smoking availability.

bNot available.

cMASP+: Mobile Anxiety Sensitivity Program for Smoking and HIV.

dQG: QuitGuide.

eART: antiretroviral therapy.

fWHO: World Health Organization.

giCO: iCarbon Monoxide.

hSSASI: Short Scale Anxiety Sensitivity Index.